An updated review on pulsatile drug delivery system
DOI:
https://doi.org/10.7439/ijap.v4i4.2309Keywords:
Monoclonal antibodies, Hybridoma technology, Immunoglobulin, Human mAbs, Cell Engineering.Abstract
Pulsatile Drug Delivery Systems are gaining a lot of interest as they deliver the drug at the right place, at the right time and in the right amount, thus providing spatial, temporal and smart delivery and increasing patient compliance. The use of pulsatile release of the drugs is desirable where constant drug release is not desired. PDDS can be classified into time controlled systems wherein the drug release is controlled primarily by the delivery system; stimuli induced PDDS in which release is controlled by the stimuli, like the pH or enzymes present in the intestinal tract or enzymes present in the drug delivery system and externally regulated system where release is programmed by external stimuli like magnetism, ultrasound, electrical effect and irradiation. The current article focuses on the diseases requiring PDDS, methodologies involved for the existing systems, current situation and future scope, recent advances in PDDS and PDDS product currently available in the market.Downloads
References
Susan Schmidt. Biocompatibility of silicon-based electrode arrays implanted in feline cortical tissue. J. of Biomedical materials research. 1993; 27(11): 1393-1399.
A.C.Evans. Diamond-like carbon applied to bioengineering materials. Surface and Coating technology. 1991; 47(1-3): 662-667.
M. Hu, T. Discrete chemical release from a microfuidic chip. J. Microelectromech. Syst. 2007; 16(4): 786
Harkness JAL, Richter MB, Panayi GS. Circadian variation in disease activity in rheumatoid arthritis. British Medical J. 1982; 284: 551-554.
Huskisson EC and GP Velo ed. Chronopharmacology of anti-rheumatic drugs with special reference to indomethacin in: Inflammatory Arthropathies. Excepta Medica. 1976: 99-105.
Bellamy N, Sothern RB, Campbell J. Rhythmic variations in pain perception in osteoarthritis of the knee. Journal of Rheumatology. 1990; 17: 364-372.
Levi F, Le Louarn C, Reinberg A. Chronotherapy of osteoarthritis patients: optimization indomethacine sustained released (ISR). Annual Review of Chronopharmacology 1984; 1: 345-348.
Lvin M, Focan-Hensard D, Levi F. Chronobiological aspects of spondylarthritis. Annual Review of Chronopharmacology. 1988; 5: 17-20.
Reinberg A, Manfredi R, Kahn MF. Tenoxicam chronotherapy of rheumatic diseases. Annual Review of Chronopharmacology. 1990; 7: 293-296.
Sharma S, Pawar SA. Low density multiparticulate system for pulsatilerelease of meloxicam. Int J Pharm. 2006; 313: 150-158.
Bhavana V, Khopade AJ, Jain VVD, Jain NK. Oral pulsatile drug delivery. Eastern pharmacist 1996; 39(464): 6-21.
Bi-Botti CY. Chronopharmaceutics: Gimmick or clinically relevant approach to drug delivery a review. J Control Rel. 2004; 98(3): 337-353.
Bjorn, L. The clinical relevance of chronopharmacology intherapeutics. Pharmacological Res.1996; 33:107-115.
Suresh S, Pathak S. Chronopharmaceutics: Emerging role of rhythms in optimizing drug therapy. Indian j Pharm Sci. 2005; 67(2):135-140.
Schafer M, Frischkopf K, Taimor G, Piper HM, Schluter KD: Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat. Am J Physiol Cell Physiol. 2000; 279(2): C495-503.
Maroni A, Zema L, Dorly Oral pulsatile delivery: Rationale and chrono pharmaceutical formulations. Int J Pharm 2010; 2(1): 201-232.
Zilpe CR, Dhumale AJ, Gudalwar DM. Development and evalution of pulsatile press coated tablets to control early morning surge. Int J Ph. 2012; 3(3):1-19.
Nayak UY, Shavi GV, Nayak Chronotherapeutic drug delivery for early morning surge in blood pressure: A programmable delivery system. Release 2009; 136:125
Schultz P. A., Kleinebudde P., New multiparticulate delayed release system. Part I: dissolution properties and release mechanism. Journal of Controlled Release. 1997;47:181
Crison J. R., Siersma P. R., Taylor M. D., Amidon G. L. Programmable oral release technology, Port Systems & Mac: a novel dosage form for time and site specific oral drug delivery. Proceed Intern Symp Control Rel Bioact Mater. 1995; 22: 278-279.
Okano T., Bae Y. H., Jacobs H., Kim S. W., Thermally on-off switching polymers for drug permeation and release. J. Control Release. 1990; 255-265.
Bae Y. H., Okano T., Kim S. W.,
Gajanan NP, Monica R, Sameer B, Anuradha R. Design, Evaluation and Comparative Study of Pulsatile Release from Tablet and Capsule Dosage Forms. Iranian J Pharma Sci Summer. 2009;5(3):119-128.
Nitin. D. Gajbhiye, Dr. Vilasrao. J. Kadam, Kisan.R. Jadhav, Anand. U. Kyatanwar, Ujas. J. Patel. Pulsatile drug delivery system. Journal of Pharmacy Research. 2010;3(1):120-3.
Ramesh D. Parmar, Rajesh K. Parikh, G. Vidyasagar, Dhaval V. Patel, Chirag J. Patel, Biraju D. Patel. Pulsatile Drug Delivery Systems: An Overview. Int J Pharma Sci and Nanotechnology. 2009;2(3):605-614.
Ravi Kumar Reddy, M.Veera Jyothsna, T. S.Mohamed Saleem2, C.Madhu Sudhana Chetty. Review On: Pulsatile Drug Delivery Systems. J. Pharm. Sci. & Res. 2009;1(4):109-115.
Gazzaniga A, Iamartino P, Maffione G, Sangalli ME. Oral delayed-release system for colonic specific delivery. Int J Pharm. 1994;2(108):77-83.
Maroni A, Sangalli ME, Cerea M, Busetti C, Giordano F, Gazzaniga A. Low viscosity HPMC coating of soft and hard gelatin capsules for delayed and colonic release: preliminary investigations on process parameters and in vitro release performances. Proceed. Int Control Rel Bioact Mater. 1999;26: 87-88.
Bhargavi R,A. Comprehensive Review of Pulsatile Drugs. International Research Journal of Pharmacy. 2012; 3(3) 106-108.
Arora S, Ahuja A. Pulsatile Drug Delivery System. Indian Journal of Pharmaceutical Sciences. 2006;68: 295-300.
Kyatanwar U.A. Pulsatile Drug Delivery System. Journal of Phamacy Research. 2010;3(1): 2015.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
